Kinetic profiling of the c-Myc transcriptome and bioinformatic analysis of repressed gene promoters

Cell Cycle

Volumn 10, Issue 13, 2011, Pages 2184-2196

  Yap, Chui Sun ^a,d   Peterson, Abigail L ^a   Castellani, Gastone ^b,c   Sedivy, John M ^a   Neretti, Nicola ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

c Myc; Expression profiling; Gene regulation; Microarray; Promoter; Proto oncogene; Transcriptome

Indexed keywords

INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; MYELOID ZINC FINGER 1; NUCLEAR FACTOR Y; NUCLEAR TRANSCRIPTION FACTOR Y ALPHA; ONCOPROTEIN; PROTEIN SFPI1; RAS PROTEIN; RAS RESPONSIVE ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR ZBTB17; TRANSCRIPTOME; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL CELL; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; FIBROBLAST; GENE CONTROL; GENE EXPRESSION PROFILING; GENE REPRESSION; GENE TARGETING; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; NULL ALLELE; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TRANSCRIPTION INITIATION; TRANSCRIPTOMICS;

MAMMALIA;

EID: 79959943250     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.13.16249     Document Type: Article

References (69)

1. Vita M, Henriksson M. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 2006; 16:318-30; Pubmed DOI: 10.1016/j.semcancer.2006.07.015.
2. Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. The c-Myc target gene network. Semin Cancer Biol 2006; 16:253-64; Pubmed DOI: 10.1016/j.semcancer.2006.07.014.
3. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer 2008; 8:976-90; Pubmed DOI: 10.1038/nrc2231.
4. Gallant P. Myc/Max/Mad in invertebrates: The evolution of the Max network. Curr Top Microbiol Immunol 2006; 302:235-53; Pubmed DOI: 10.1007/3-540-32952-8-9.
5. Arvanitis C, Felsher DW. Conditional transgenic models define how MYC initiates and maintains tumorigenesis. Semin Cancer Biol 2006; 16:313-7; Pubmed DOI: 10.1016/j.semcancer.2006.07.012.
6. 1 phase progression both before and after the restriction point. Mol Biol Cell 2003; 14:823-35; Pubmed DOI: 10.1091/mbc.E02-10-0649.
7. Meyer N, Kim SS, Penn LZ. The Oscar-worthy role of Myc in apoptosis. Semin Cancer Biol 2006; 16:275-87; Pubmed DOI: 10.1016/j.semcancer.2006.07.011.
8. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411:342-8; Pubmed DOI: 10.1038/35077213.
9. Blackwood EM, Eisenman RN. Max: A helix-loophelix zipper protein that forms a sequence-specific DNA-binding complex with myc. Science 1991; 251:1211-7; Pubmed DOI: 10.1126/science.2006410.
10. Blackwell TK, Huang J, Ma A, Kretzner L, Alt FW, Eisenman RN, et al. Binding of Myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol 1993; 13:5216-24; PubMed.
11. Cowling VH, Cole MD. Mechanism of transcriptional activation by the Myc oncoproteins. Semin Cancer Biol 2006; 16:242-52; Pubmed DOI: 10.1016/j.semcancer.2006.08.001.
12. Eilers M, Eisenman RN. Myc's broad reach. Genes Dev 2008; 22:2755-66; Pubmed DOI: 10.1101/gad.1712408.
13. Kim J, Lee JH, Iyer VR. Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo. PLoS One 2008; 3:1798.
14. Remondini D, O'Connell B, Intrator N, Sedivy JM, Neretti N, Castellani GC, et al. Targeting c-Mycactivated genes with a correlation method: detection of global changes in large gene expression network dynamics. Proc Natl Acad Sci USA 2005; 102:6902-6; Pubmed DOI: 10.1073/pnas.0502081102.
15. O'Connell BC, Cheung AF, Simkevich CP, Tam W, Ren X, Mateyak MK, et al. A large scale genetic analysis of c-Myc-regulated gene expression patterns. J Biol Chem 2003; 278:12563-73; Pubmed DOI: 10.1074/jbc.M210462200.
16. Mateyak MK, Obaya AJ, Adachi S, Sedivy JM. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 1997; 8:1039-48; PubMed.
17. Mateyak MK, Obaya AJ, Sedivy JM. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol 1999; 19:4672-83; PubMed.
18. Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res 1995; 23:1686-90; Pubmed DOI: 10.1093/nar/23.10.1686.
19. Storey JD, Tibshirani R. Statistical significance for genome-wide studies. Proc Natl Acad Sci USA 2003; 100:9440-5; Pubmed DOI: 10.1073/pnas.1530509100.
20. Liu YC, Li F, Handler J, Huang CR, Xiang Y, Neretti N, et al. Global regulation of nucleotide biosynthetic genes by c-Myc. PLoS ONE 2008; 3:2722; Pubmed DOI: 10.1371/journal.pone.0002722.
21. Morrish F, Neretti N, Sedivy JM, Hockenbery DM. The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry. Cell Cycle 2008; 7:1054-66; Pubmed DOI: 10.4161/cc.7.8.5739.
22. Beissbarth T, Speed TP. GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics 2004; 20:1464-5; Pubmed DOI: 10.1093/bioinformatics/bth088.
23. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102:15545-50; Pubmed DOI: 10.1073/pnas.0506580102.
24. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. The KEGG resource for deciphering the genome. Nucleic Acids Res 2004; 32:277-80; Pubmed DOI: 10.1093/nar/gkh063.
25. Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res 2009; 15:6479-83; Pubmed DOI: 10.1158/1078-0432.CCR-09-0889.
26. Fry AM, Yamano H. APC/C-mediated degradation in early mitosis: how to avoid spindle assembly checkpoint inhibition. Cell Cycle 2006; 5:1487-91; Pubmed DOI: 10.4161/cc.5.14.3003.
27. Nasmyth K. How do so few control so many? Cell 2005; 120:739-46; Pubmed DOI: 10.1016/j.cell.2005.03.006.
28. Yu H. Cdc20: a WD40 activator for a cell cycle degradation machine. Mol Cell 2007; 27:3-16; Pubmed DOI: 10.1016/j.molcel.2007.06.009.
29. Tang Z, Li B, Bharadwaj R, Zhu H, Ozkan E, Hakala K, et al. APC2 Cullin protein and APC11 RING protein comprise the minimal ubiquitin ligase module of the anaphase-promoting complex. Mol Biol Cell 2001; 12:3839-51; PubMed.
30. Shim H, Chun YS, Lewis BC, Dang CV. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc Natl Acad Sci USA 1998; 95:1511-6; Pubmed DOI: 10.1073/pnas.95.4.1511.
31. Osthus RC, Shim H, Kim S, Li Q, Reddy R, Mukherjee M, et al. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem 2000; 275:21797-800; Pubmed DOI: 10.1074/jbc.C000023200.
32. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2007; 2:2366-82; Pubmed DOI: 10.1038/nprot.2007.324.
33. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 2004; 32:91-4; Pubmed DOI: 10.1093/nar/gkh012.
34. Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R, et al. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 2003; 31:374-8; Pubmed DOI: 10.1093/nar/gkg108.
35. Frith MC, Fu Y, Yu L, Chen JF, Hansen U, Weng Z. Detection of functional DNA motifs via statistical overrepresentation. Nucleic Acids Res 2004; 32:1372-81; Pubmed DOI: 10.1093/nar/gkh299.
36. Herkert B, Eilers M. Transcriptional repression: The dark side of Myc. Genes Cancer 2010; 1:580-6; doi:10.1177/1947601910379012.
37. Roy AL, Carruthers C, Gutjahr T, Roeder RG. Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature 1993; 365:359-61; Pubmed DOI: 10.1038/365359a0.
38. Shrivastava A, Saleque S, Kalpana GV, Artandi S, Goff SP, Calame K. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 1993; 262:1889-92; Pubmed DOI: 10.1126/science.8266081.
39. Shrivastava A, Yu J, Artandi S, Calame K. YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels. Proc Natl Acad Sci USA 1996; 93:10638-41; Pubmed DOI: 10.1073/pnas.93.20.10638.
40. Peukert K, Staller P, Schneider A, Carmichael G, Hanel F, Eilers M. An alternative pathway for gene regulation by Myc. EMBO J 1997; 16:5672-86; Pubmed DOI: 10.1093/emboj/16.18.5672.
41. Gartel AL, Ye X, Goufman E, Shianov P, Hay N, Najmabadi F, et al. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci USA 2001; 98:4510-5; Pubmed DOI: 10.1073/pnas.081074898.
42. Izumi H, Molander C, Penn LZ, Ishisaki A, Kohno K, Funa K. Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor. J Cell Sci 2001; 114:1533-44; PubMed.
43. Wang CY, Petryniak B, Ho IC, Thompson CB, Leiden JM. Evolutionarily conserved Ets family members display distinct DNA binding specificities. J Exp Med 1992; 175:1391-9; Pubmed DOI: 10.1084/jem.175.5.1391.
44. Brown TA, McKnight SL. Specificities of protein-protein and protein-DNA interaction of GABPalpha and two newly defined ets-related proteins. Genes Dev 1992; 6:2502-12; Pubmed DOI: 10.1101/gad.6.12b.2502.
45. John S, Marais R, Child R, Light Y, Leonard WJ. Importance of low affinity Elf-1 sites in the regulation of lymphoid-specific inducible gene expression. J Exp Med 1996; 183:743-50; Pubmed DOI: 10.1084/jem.183.3.743.
46. Mao X, Miesfeldt S, Yang H, Leiden JM, Thompson CB. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. J Biol Chem 1994; 269:18216-22; PubMed.
47. Nye JA, Petersen JM, Gunther CV, Jonsen MD, Graves BJ. Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif. Genes Dev 1992; 6:975-90; Pubmed DOI: 10.1101/gad.6.6.975.
48. Gaboli M, Kotsi PA, Gurrieri C, Cattoretti G, Ronchetti S, Cordon-Cardo C, et al. Mzf1 controls cell proliferation and tumorigenesis. Genes Dev 2001; 15:1625-30; Pubmed DOI: 10.1101/gad.902301.
49. Hsieh YH, Wu TT, Huang CY, Hsieh YS, Liu JY. Suppression of tumorigenicity of human hepatocellular carcinoma cells by antisense oligonucleotide MZF-1. Chin J Physiol 2007; 50:9-15; PubMed.
50. Thiagalingam A, De Bustros A, Borges M, Jasti R, Compton D, Diamond L, et al. RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol 1996; 16:5335-45; PubMed.
51. Mukhopadhyay NK, Cinar B, Mukhopadhyay L, Lutchman M, Ferdinand AS, Kim J, et al. The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer. Mol Endocrinol 2007; 21:2056-70; Pubmed DOI: 10.1210/me.2006-0503.
52. Yet SF, McA'Nulty MM, Folta SC, Yen HW, Yoshizumi M, Hsieh CM, et al. Human EZF, a Kruppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J Biol Chem 1998; 273:1026-31; Pubmed DOI: 10.1074/jbc.273.2.1026.
53. Patel S, Xi ZF, Seo EY, McGaughey D, Segre JA. Klf4 and corticosteroids activate an overlapping set of transcriptional targets to accelerate in utero epidermal barrier acquisition. Proc Natl Acad Sci USA 2006; 103:18668-73; Pubmed DOI: 10.1073/pnas.0608658103.
54. Rowland BD, Bernards R, Peeper DS. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 2005; 7:1074-82; Pubmed DOI: 10.1038/ncb1314.
55. Hanna JH, Saha K, Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 2010; 143:508-25; Pubmed DOI: 10.1016/j.cell.2010.10.008.
56. Scheper W, Copray S. The molecular mechanism of induced pluripotency: a two-stage switch. Stem Cell Rev 2009; 5:204-23; Pubmed DOI: 10.1007/s12015-009- 9077-x.
57. Dang CV. Enigmatic MYC conducts an unfolding systems biology symphony. Genes Cancer 2010; 1:526-31; Pubmed DOI: 10.1177/1947601910378742.
58. Kleine-Kohlbrecher D, Adhikary S, Eilers M. Mechanisms of transcriptional repression by Myc. Curr Top Microbiol Immunol 2006; 302:51-62; Pubmed DOI: 10.1007/3-540-32952-8-3.
59. Agrawal P, Yu K, Salomon AR, Sedivy JM. Proteomic profiling of Myc-associated proteins. Cell Cycle 2010; 9:4908-21; Pubmed DOI: 10.4161/cc.9.24.14199.
60. Wasylishen AR, Penn LZ. Myc: The beauty and the beast. Genes Cancer 2010; 1:532-41; DOI: 10.1177/1947601910378024.
61. Bui TV, Mendell JT. Myc: Maestro of microRNAs. Genes Cancer 2010; 1:568-75; Pubmed DOI: 10.1177/1947601910377491.
62. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435:839-43; Pubmed DOI: 10.1038/nature03677.
63. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 2008; 28:2167-74; Pubmed DOI: 10.1128/MCB.01977-07.
64. Frenzel F, Lovén J, Henriksson MA. Targeting MYC-regulated miRNAs to combat cancer. Genes Cancer 2010; 1:660-7; DOI: 10.1177/1947601910377488.
65. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40:43-50; Pubmed DOI: 10.1038/ng.2007.30.
66. Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M, et al. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci USA 2009; 106:3384-9; Pubmed DOI: 10.1073/pnas.0808300106.
67. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 2005; 33:175; Pubmed DOI: 10.1093/nar/gni179.
68. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34:267-73; Pubmed DOI: 10.1038/ng1180.
69. Roy AL, Meisterernst M, Pognonec P, Roeder RG. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature 1991; 354:245-8; Pubmed DOI: 10.1038/354245a0.